Market Research Report
Connected Drug Injection Devices to 2024
|Published by||Greystone Research Associates||Product code||352396|
Delivery time: 1-2 business days
|Connected Drug Injection Devices to 2024|
|Published: November 19, 2018||Content info:||
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient's quality-of-life. Connected drug injection devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants. Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.